We are live on ! Find out more
TCM

TCG Crossover Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 1,165.83%
This Fund
S&P 500
This Quarter Est. Return
+32.25%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$610M
AUM Growth
+$96.8M
Cap. Flow
-$39.5M
Cap. Flow %
-6.48%
Top 10 Hldgs %
80.69%
Holding
24
New
2
Increased
4
Reduced
1
Closed
2

Top Buys

1
ICVX
Icosavax, Inc. Common Stock
ICVX
+$29.6M
2
COGT icon
Cogent Biosciences
COGT
+$22.9M
3
JBIO
Jade Biosciences
JBIO
+$20.5M
4
GERN icon
Geron
GERN
+$16.6M
5
ANTX icon
AN2 Therapeutics
ANTX
+$9.27M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$95M
2
CBAY
Cymabay Therapeutics
CBAY
+$26.6M
3
VRDN icon
Viridian Therapeutics
VRDN
+$16.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$96.3M 15.8%
2,448,829
-2,692,289
-52% -$95M
GERN icon
2
Geron
GERN
$911M
$75.7M 12.42%
23,589,779
+5,824,566
+33% +$16.6M
COGT icon
3
Cogent Biosciences
COGT
$6.43B
$66.7M 10.93%
5,631,042
+2,000,000
+55% +$22.9M
VECT
4
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$52.9M 8.68%
3,113,600
– –
JBIO
5
Jade Biosciences
JBIO
$1.26B
$37.8M 6.19%
62,894
+32,000
+104% +$20.5M
ICVX
6
DELISTED
Icosavax, Inc. Common Stock
ICVX
$36.8M 6.03%
+3,703,704
New +$29.6M
MDGL icon
7
Madrigal Pharmaceuticals
MDGL
$12.4B
$34.6M 5.68%
149,917
– –
TYRA icon
8
Tyra Biosciences
TYRA
$1.87B
$33.9M 5.56%
1,989,103
– –
KALV
9
DELISTED
KalVista Pharmaceuticals
KALV
$30.6M 5.01%
3,395,495
– –
VTYX
10
DELISTED
Ventyx Biosciences
VTYX
$26.8M 4.39%
815,724
– –
DYN icon
11
Dyne Therapeutics
DYN
$3.73B
$18.6M 3.04%
1,650,150
– –
KURA icon
12
Kura Oncology
KURA
$958M
$15.1M 2.47%
1,423,642
– –
GPCR icon
13
Structure Therapeutics
GPCR
$3.29B
$14.5M 2.39%
350,000
– –
IMVT icon
14
Immunovant
IMVT
$7.94B
$12.4M 2.04%
654,853
– –
SLN
15
Silence Therapeutics
SLN
$491M
$11.6M 1.9%
2,104,875
– –
ANTX icon
16
AN2 Therapeutics
ANTX
$169M
$11M 1.8%
+1,289,320
New +$9.27M
TRDA icon
17
Entrada Therapeutics
TRDA
$261M
$8.86M 1.45%
584,955
– –
MRUS
18
DELISTED
Merus
MRUS
$7.9M 1.3%
300,000
– –
CABA icon
19
Cabaletta Bio
CABA
$424M
$6.28M 1.03%
486,795
– –
ACRS icon
20
Aclaris Therapeutics
ACRS
$739M
$5.49M 0.9%
529,839
– –
CCCC icon
21
C4 Therapeutics
CCCC
$391M
$3.51M 0.58%
1,276,574
+26,574
+2% +$85.4K
ALPN
22
DELISTED
Alpine Immune Sciences Inc
ALPN
$2.6M 0.43%
253,069
– –
VRDN icon
23
Viridian Therapeutics
VRDN
$1.97B
– –
-663,610
Closed -$16.9M
CBAY
24
DELISTED
Cymabay Therapeutics
CBAY
– –
-3,048,257
Closed -$26.6M

Similar funds

DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.51B AUM 39.24% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return